Follow
Charles L. Burton
Charles L. Burton
Associate Research Scientist, Yale School of Public Health
Verified email at yale.edu
Title
Cited by
Cited by
Year
Regulatory flexibility: An individual differences perspective on coping and emotion regulation
GA Bonanno, CL Burton
Perspectives on psychological science 8 (6), 591-612, 2013
17962013
Coping flexibility, potentially traumatic life events, and resilience: A prospective study of college student adjustment
IR Galatzer-Levy, CL Burton, GA Bonanno
Journal of Social and Clinical Psychology 31 (6), 542-567, 2012
4022012
The burden of stigma on health and well-being: A taxonomy of concealment, course, disruptiveness, aesthetics, origin, and peril across 93 stigmas
JE Pachankis, ML Hatzenbuehler, K Wang, CL Burton, FW Crawford, ...
Personality and Social Psychology Bulletin 44 (4), 451-474, 2018
2382018
Sex, status, competition, and exclusion: Intraminority stress from within the gay community and gay and bisexual men’s mental health.
JE Pachankis, KA Clark, CL Burton, JMW Hughto, R Bränström, ...
Journal of personality and social psychology 119 (3), 713, 2020
1632020
Measuring ability to enhance and suppress emotional expression: The Flexible Regulation of Emotional Expression (FREE) Scale.
CL Burton, GA Bonanno
Psychological assessment 28 (8), 929, 2016
1342016
Coping flexibility and complicated grief: A comparison of American and Chinese samples
CL Burton, OH Yan, R Pat‐Horenczyk, ISF Chan, S Ho, GA Bonanno
Depression and Anxiety 29 (1), 16-22, 2012
1132012
Body dissatisfaction and eating disorders in a sample of gay and bisexual men
D Siconolfi, PN Halkitis, TW Allomong, CL Burton
International Journal of Men's Health 8 (3), 254, 2009
892009
Psychotherapy for the spectrum of sexual minority stress: Application and technique of the ESTEEM treatment model
CL Burton, K Wang, JE Pachankis
Cognitive and Behavioral Practice 26 (2), 285-299, 2019
862019
Project ESTEEM protocol: a randomized controlled trial of an LGBTQ-affirmative treatment for young adult sexual minority men’s mental and sexual health
JE Pachankis, EM McConocha, JS Reynolds, R Winston, O Adeyinka, ...
BMC Public Health 19, 1-12, 2019
822019
Familial social support predicts a reduced cortisol response to stress in sexual minority young adults
CL Burton, GA Bonanno, ML Hatzenbuehler
Psychoneuroendocrinology 47, 241-245, 2014
792014
Treatment type and demographic characteristics as predictors for cancer adjustment: Prospective trajectories of depressive symptoms in a population sample.
CL Burton, IR Galatzer-Levy, GA Bonanno
Health psychology 34 (6), 602, 2015
712015
Depression and substance use: towards the development of an emotion regulation model of stigma coping
K Wang, CL Burton, JE Pachankis
Substance Use & Misuse 53 (5), 859-866, 2018
562018
Hydrocortisone responsiveness in Gulf War veterans with PTSD: Effects on ACTH, declarative memory hippocampal [18F] FDG uptake on PET
R Yehuda, JA Golier, LM Bierer, A Mikhno, LC Pratchett, CL Burton, ...
Psychiatry Research: Neuroimaging 184 (2), 117-127, 2010
422010
Risk from within: Intraminority gay community stress and sexual risk-taking among sexual minority men
CL Burton, KA Clark, JE Pachankis
Annals of Behavioral Medicine 54 (9), 703-712, 2020
392020
Does getting stigma under the skin make it thinner? Emotion regulation as a stress-contingent mediator of stigma and mental health
CL Burton, K Wang, JE Pachankis
Clinical Psychological Science 6 (4), 590-600, 2018
282018
The suppression paradox: A cross-cultural comparison of suppression frequency, suppression ability, and depression
S Chen, CL Burton, GA Bonanno
Journal of Affective Disorders 274, 183-189, 2020
222020
Regulatory flexibility and its role in adaptation to aversive events throughout the lifespan.
CL Burton, GA Bonanno
American Psychological Association, 2016
162016
On the quantitative study of multiple marginalization: Paradox and potential solution.
C Rodriguez-Seijas, CL Burton, O Adeyinka, JE Pachankis
Stigma and Health 4 (4), 495, 2019
122019
Transdiagnostic approaches to improve sexual minority individuals' co-occurring mental, behavioral, and sexual health.
C Rodriguez-Seijas, CL Burton, JE Pachankis
Oxford University Press, 2019
92019
A phase 1 placebo-controlled study in volunteers of escalating doses of HYB2055, a second-generation immunomodulatory agent based on CpG DNA.
R Martin, T Sullivan, L Bhagat, E Kandimalla, D Wang, Q Zhao, C Burton, ...
CLINICAL CANCER RESEARCH 9 (16), 6227S-6227S, 2003
52003
The system can't perform the operation now. Try again later.
Articles 1–20